BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15093608)

  • 1. Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK.
    Chang HC; Liu LT; Hung WC
    Cell Signal; 2004 Jun; 16(6):675-9. PubMed ID: 15093608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion.
    Hsu MC; Chang HC; Hung WC
    J Biol Chem; 2006 Feb; 281(8):4718-25. PubMed ID: 16377629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
    Choi HS; Lee JH; Park JG; Lee YI
    Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter.
    Lee KJ; Lee KY; Lee YM
    Biochim Biophys Acta; 2010 May; 1803(5):608-16. PubMed ID: 20080132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
    Liu LT; Chang HC; Chiang LC; Hung WC
    Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.
    Yeh HH; Tseng YF; Hsu YC; Lan SH; Wu SY; Raghavaraju G; Cheng DE; Lee YR; Chang TY; Chow NH; Hung WC; Liu HS
    BMC Cancer; 2015 Mar; 15():172. PubMed ID: 25885317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.
    Chang HC; Cho CY; Hung WC
    Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
    Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
    Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional control of the RECK metastasis/angiogenesis suppressor gene.
    Sasahara RM; Brochado SM; Takahashi C; Oh J; Maria-Engler SS; Granjeiro JM; Noda M; Sogayar MC
    Cancer Detect Prev; 2002; 26(6):435-43. PubMed ID: 12507228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RECK is a target of Epstein-Barr virus latent membrane protein 1.
    Liu LT; Peng JP; Chang HC; Hung WC
    Oncogene; 2003 Nov; 22(51):8263-70. PubMed ID: 14614450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression.
    Jeon HW; Lee YM
    Mol Cancer Ther; 2010 May; 9(5):1361-70. PubMed ID: 20442303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role of mitogen-activated protein kinase pathway and c-Jun induction in epidermal growth factor-induced gene expression of human 12-lipoxygenase.
    Chen BK; Kung HC; Tsai TY; Chang WC
    Mol Pharmacol; 2000 Jan; 57(1):153-61. PubMed ID: 10617690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated expression and function of the RECK tumor suppressor under hypoxic conditions is mediated by the MAPK signaling pathways.
    Jeon HW; Lee KJ; Lee SH; Kim WH; Lee YM
    Arch Pharm Res; 2011 Jan; 34(1):137-45. PubMed ID: 21468925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex.
    Bu Y; Gelman IH
    J Biol Chem; 2007 Sep; 282(37):26725-26739. PubMed ID: 17626016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.
    Siddesha JM; Valente AJ; Sakamuri SS; Yoshida T; Gardner JD; Somanna N; Takahashi C; Noda M; Chandrasekar B
    J Mol Cell Cardiol; 2013 Dec; 65():9-18. PubMed ID: 24095877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
    Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
    Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.